268 related articles for article (PubMed ID: 37144511)
1. The human microbiome links to prostate cancer risk and treatment (Review).
Xia B; Wang J; Zhang D; Hu X
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144511
[TBL] [Abstract][Full Text] [Related]
2. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.
Kustrimovic N; Bombelli R; Baci D; Mortara L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675055
[TBL] [Abstract][Full Text] [Related]
3. The microbiome in prostate inflammation and prostate cancer.
Porter CM; Shrestha E; Peiffer LB; Sfanos KS
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):345-354. PubMed ID: 29795140
[TBL] [Abstract][Full Text] [Related]
4. Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial.
Newton RU; Christophersen CT; Fairman CM; Hart NH; Taaffe DR; Broadhurst D; Devine A; Chee R; Tang CI; Spry N; Galvão DA
BMJ Open; 2019 Apr; 9(4):e024872. PubMed ID: 30987986
[TBL] [Abstract][Full Text] [Related]
5. The Microbiome and Prostate Cancer Risk.
Wheeler KM; Liss MA
Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090
[TBL] [Abstract][Full Text] [Related]
6. [Effects of androgen deprivation therapy for prostate cancer on gut microbiota and treatment].
Liu JY; Zhu YP; Han BM; Xia SJ
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(2):84-88. PubMed ID: 36597735
[TBL] [Abstract][Full Text] [Related]
7. Human microbiome and prostate cancer development: current insights into the prevention and treatment.
Ohadian Moghadam S; Momeni SA
Front Med; 2021 Feb; 15(1):11-32. PubMed ID: 32607819
[TBL] [Abstract][Full Text] [Related]
8. Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling.
Bui NN; Li CY; Wang LY; Chen YA; Kao WH; Chou LF; Hsieh JT; Lin H; Lai CH
J Microbiol Immunol Infect; 2023 Apr; 56(2):246-256. PubMed ID: 36639348
[TBL] [Abstract][Full Text] [Related]
9. Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer.
Salachan PV; Sørensen KD
J Exp Clin Cancer Res; 2022 Jan; 41(1):31. PubMed ID: 35065652
[TBL] [Abstract][Full Text] [Related]
10. Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha C; Peng Z; Huang K; Tang K; Wang Q; Zhu L; Che B; Li W; Xu S; Huang T; Yu Y; Zhang W
Front Oncol; 2023; 13():1196217. PubMed ID: 37265797
[TBL] [Abstract][Full Text] [Related]
11. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
12. The Microbiome and Genitourinary Cancer: A Collaborative Review.
Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
[TBL] [Abstract][Full Text] [Related]
14. Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling.
Salachan PV; Rasmussen M; Fredsøe J; Ulhøi B; Borre M; Sørensen KD
Genome Med; 2022 Jan; 14(1):9. PubMed ID: 35078527
[TBL] [Abstract][Full Text] [Related]
15. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell and mesenchymal cell cooperative actions in metastasis progression and hormone resistance in prostate cancer: Potential role of androgen and gonadotropin‑releasing hormone receptors (Review).
Contreras HR; López-Moncada F; Castellón EA
Int J Oncol; 2020 May; 56(5):1075-1082. PubMed ID: 32319606
[TBL] [Abstract][Full Text] [Related]
17. The potential role of the microbiota in prostate cancer pathogenesis and treatment.
Pernigoni N; Guo C; Gallagher L; Yuan W; Colucci M; Troiani M; Liu L; Maraccani L; Guccini I; Migliorini D; de Bono J; Alimonti A
Nat Rev Urol; 2023 Dec; 20(12):706-718. PubMed ID: 37491512
[TBL] [Abstract][Full Text] [Related]
18. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
[TBL] [Abstract][Full Text] [Related]
19. Exercise and prostate cancer: From basic science to clinical applications.
Campos C; Sotomayor P; Jerez D; González J; Schmidt CB; Schmidt K; Banzer W; Godoy AS
Prostate; 2018 Jun; 78(9):639-645. PubMed ID: 29569731
[TBL] [Abstract][Full Text] [Related]
20. Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer.
Kalinen S; Kallonen T; Gunell M; Ettala O; Jambor I; Knaapila J; Syvänen KT; Taimen P; Poutanen M; Aronen HJ; Ollila H; Pietilä S; Elo LL; Lamminen T; Hakanen AJ; Munukka E; Boström PJ;
Eur Urol Open Sci; 2024 Apr; 62():140-150. PubMed ID: 38500636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
